-65%

est. 2Y upside i

HealthcareSeries A

Rank

#938

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Low

M7 Health presents a risky equity opportunity with moderate upside potential (estimated 89.5% expected upside over 2 years) for a job seeker.

Last updated: March 10, 2026

Bull (25%)+350%

M7 Health's 'nurse-first' AI platform achieves widespread adoption, doubling its footprint as planned and expanding into new health systems. Its AI scheduling capabilities become a critical differentiator, leading to significant revenue growth (e.g., $30M-$40M ARR) and a valuation of $200M-$250M.

Base (40%)+75%

M7 Health continues to grow steadily, securing more hospital contracts and enhancing its platform. It maintains its niche against broader EHR solutions by focusing on nurse-centric design, reaching $10M-$15M ARR and a valuation of $80M-$90M.

Bear (35%)-80%

Dominant EHR providers like Epic or Cerner integrate advanced nurse scheduling modules, or well-funded direct competitors like IntelyCare or SnapCare gain significant market share. M7 Health struggles to scale beyond its initial customer base, leading to a down round or acquisition at a valuation of $10M-$15M, significantly impacting common stock value due to liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

M7 Health has raised $17M in total funding. At an estimated current valuation of $50M (post-money Series A), investors hold $17M in liquidation preferences, meaning common shareholders would only see returns after this amount is paid out.

Dilution Risk

high

As a Series A company, M7 Health will likely need to raise additional funding rounds (Series B, C) to scale, which will lead to further dilution for existing equity holders.

Secondary Liquidity

none

Given its early stage (Series A), there is no active secondary market for M7 Health's equity, limiting opportunities for early liquidity.

Questions to Ask at the Interview

Strategic questions based on M7 Health's data — designed to show you've done your homework.

  • 1

    “Given the stated 'medium' incumbent threat from large EHR providers like Epic and Cerner, what specific strategies is M7 Health employing to ensure deep integration and prevent these incumbents from replicating or acquiring competing nurse workforce management modules?”

  • 2

    “M7 Health has agreements to double its footprint by year-end (as of July 2025). What are the key metrics the company is tracking to measure the success of this expansion, and how does the current revenue scale support the next funding round?”

  • 3

    “With $17M raised and likely more funding rounds ahead, how does M7 Health plan to manage potential future dilution for employees, and what is the realistic timeline for a liquidity event for common shareholders?”

Community

Valuation Sentiment

Our model estimates -65% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.